Meeting News

Robotic retinal surgery could mitigate human limitations

October 14, 2019
SAN FRANCISCO — Robotic-assisted or fully robotic retinal surgery could improve patient outcomes by mitigating human limitations, according to…

Meeting News

Dry AMD patients treated with risuteganib gain more BCVA improvement

October 13, 2019
SAN FRANCISCO — More patients with dry age-related macular degeneration treated with risuteganib, a small synthetic peptide that regulates…

Meeting News

In-office gene therapy injection maintains BCVA through 24 weeks in wet AMD patients

October 13, 2019
SAN FRANCISCO — Patients with wet age-related macular degeneration in the OPTIC trial treated with one in-office injection of ADVM-022, a gene…

Meeting News

Phase 3 data presented for CEDAR, SEQUOIA studies

October 12, 2019
SAN FRANCISCO — Vision gains achieved in the first year of the CEDAR and SEQUOIA studies were maintained in the second year with only four…

Meeting News

Long-term use of pentosan polysulfate sodium associated with vision-threatening maculopathy

October 12, 2019
SAN FRANCISCO — Long-term use of pentosan polysulfate sodium is strongly associated with vision-threatening pentosan polysulfate maculopathy, a…

Meeting News

Viscous topical anesthetics increased risk of post-injection endophthalmitis

October 11, 2019
SAN FRANCISCO — Patients with wet age-related macular degeneration and diabetic macular edema who received viscous topical anesthetics before…

Meeting News

Hypersonic vitrectomy has potential to replace guillotine vitrectomy cutters

October 11, 2019
SAN FRANCISCO — Hypersonic vitrectomy devices, a method of vitreous removal in which ultrasonic power is used to actuate a vitrectomy probe…

FDA News

Glaukos completes enrollment in iStent infinite trial

October 11, 2019
Glaukos has completed patient enrollment in an FDA investigational device exemption trial for the iStent infinite trabecular micro-bypass system. The…

In the JournalsPerspective

Patients with retinal vein occlusions have increased mortality risk

October 11, 2019
Patients with retinal vein occlusions have an increased risk of cardiovascular events and all-cause mortality, according to a study. “Given the…

In the JournalsPerspective

RPE damage continues in patients with severe HCQ retinopathy after drug cessation

October 10, 2019
Severe retinal pigment epithelial damage after long-term drug cessation in patients with hydroxychloroquine retinopathy may lead to injury that…

Optometry industry supports World Sight Day

October 9, 2019
Members of the ophthalmic industry have joined to support and recognize World Sight Day, which is officially commemorated on Oct. 10 this year. The…

In the JournalsPerspective

Retinal vein occlusion linked to high cholesterol

October 9, 2019
Patients are at a higher risk of developing retinal vein occlusion if they have high-density lipoprotein cholesterol, according to a study conducted…

WHO report finds 1 billion worldwide with preventable vision impairment

October 8, 2019
The WHO’s first world report on vision details how 2.2 billion people in the world have vision impairment or blindness, with more than 1…

Perspective

FDA approves Novartis’ Beovu for wet AMD

October 8, 2019
The FDA has approved Beovu for the treatment of wet age-related macular degeneration, Novartis announced in a press release. Beovu…

Konan Medical releases automated pupillograph in US

October 7, 2019
Konan Medical announced the U.S. release of EyeKinetix, an automated objective pupillograph. EyeKinetix features an automated test to assess relative…

Blog

BLOG: What do these retinal surgery abbreviations mean?

October 4, 2019
Do you ever look at a patient’s chart and your eyes cross from all the surgical abbreviations? It looks something like this: s/p PPV/FAx/EL/SO…

ReNeuron’s cell therapy for retinitis pigmentosa shows mixed results

October 3, 2019
ReNeuron’s human retinal progenitor cell therapy candidate for retinitis pigmentosa has shown a mean improvement in visual acuity in a phase…

Second Sight given $2.4 million NIH grant

October 2, 2019
The National Institutes of Health have awarded a $2.4 million 4-year grant to Second Sight Medical Products for the development of spatial…

In the JournalsPerspective

Dark chocolate not shown to benefit retinal blood flow, visual function vs. milk chocolate

September 30, 2019
Study participants who consumed flavanol-rich dark chocolate experienced no beneficial effects in retinal perfusion or visual function compared with…

Bevacizumab recall tops September news

September 30, 2019
September’s top ophthalmology-related news included FDA advancements for multiple drugs and a notable recall of bevacizumab. Here are the top…